2011-10-11T15:25:31-05:00 2010-12-31 MORISON COGEN LLP 150 MONUMENT RD - SUITE 500 BALA CYNWYD PA 19004 990 2010-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 WILLIAM MCGIVNEY 2156900300 2011-10-06 1 JOSEPH M KISTNER CPA 2674403000 2010 2016-03-07 17:11:31Z WILLIAM MCGIVNEY 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 25404019 0 X WWW.NCCN.ORG X 1993 DE NCCN IS DEDICATED TO IMPROVING CARE ALONG THE CONTINUUM OF CANCER SCREENING, DIAGNOSIS, TREATMENT, AND FOLLOW UP. AN ALLIANCE OF 21 OF THE WORLD'S LEADING CANCER CENTERS, NCCN COMMUNICATES SOUND, EVALUATIVE CLINICAL INFORMATION TO ENHANCE THE DECISION-MAKING PROCESSESS OF PATIENTS, PHYSICIANS, AND OTHERS WHO INFLUENCE ACCESS TO AND THE CHOICE OF CANCER CARE.PART I LINE 6 VOLUNTEERS:NCCN HAD 935 VOLUNTEERS COMMIT APPROXIMATELY 16,830 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. 21 21 89 935 236299 -19687 22379720 22254488 2255271 2761376 181254 151856 695210 236299 25511455 25404019 2336551 2026838 0 0 8548090 9292567 0 0 824501 18061062 15058761 28945703 26378166 -3434248 -974147 29508232 32551069 5124880 9049725 24383352 23501344 X NCCN IS DEDICATED TO IMPROVING CARE ALONG THE CONTINUUM OF CANCER SCREENING, DIAGNOSIS, TREATMENT, AND FOLLOW-UP. AN ALLIANCE OF 21 OF THE WORLD'S LEADING CANCER CENTERS, NCCN COMMUNICATES SOUND, EVALUATIVE CLINICAL INFORMATION TO ENHANCE THE DECISION-MAKING PROCESSES OF PATIENTS, PHYSICIANS, AND OTHERS WHO INFLUENCE ACCESS TO AND THE CHOICE OF CANCER CARE. 0 0 10813841 0 2476172 WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES FREE DISTRIBUTION OF CONTENT, AND EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT. 5365440 DEVELOP OUTCOMES OF CARE STUDIES TO ASSESS THE VIABILITY OF CANCER TREATMENT GUIDELINES TO MEASURE CLINICAL AND NON-CLINICAL OUTCOMES OF CARE DELIVERED UNDER NCCN GUIDELINES. 3589214 521503 DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALITY SERVICES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ASSESS THE QUALITY OF CARE. 3001043 2026838 DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE THE STATE-OF-THE-ART IN CANCER CARE. 3001043 2026838 22769538 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 262 0 89 1 1 1 0 0 0 0 0 0 0 X 21 21 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 1 1 AL AK AZ AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X LISA KIMBRO 2156900300 275 COMMERCE DRIVE SUITE 300 FORT WASHINGTON PA 19034 AL B BENSON III MD 3.00 X 0 0 0 JORDAN D BERLIN MD 3.00 X 0 0 0 ROBERT W CARLSON MD 3.00 X 0 0 0 PETER CARROLL MD 3.00 X 0 0 0 WILLIAM E CARSON III MD 3.00 X 0 0 0 PETER F COCCIA MD 3.00 X 0 0 0 THOMAS A D'AMICO MD CHAIR 3.00 X 0 0 0 TIMOTHY J EBERLEIN MD 3.00 X 0 0 0 PAUL F ENGSTROM MD FACP 3.00 X 0 0 0 DAVID S ETTINGER MD 3.00 X 0 0 0 MICHAEL A FRIEDMAN MD 3.00 X 0 0 0 DAVID C HOHN MD 3.00 X 0 0 0 SEAN J MULVIHILL MD 3.00 X 0 0 0 DAVID G PFISTER MD 3.00 X 0 0 0 NICOLAS C PORTER 3.00 X 0 0 0 F MARC STEWART MD 3.00 X 0 0 0 WILLIAM P VAUGHAN MD MBA 3.00 X 0 0 0 MARCY B WALDINGER MHSA 3.00 X 0 0 0 RANDAL S WEBER MD 3.00 X 0 0 0 JANE C WEEKS MD MSC 3.00 X 0 0 0 FURHAN YUNUS MD FACP 3.00 X 0 0 0 WILLIAM MCGIVNEY PHD 40.00 X 655476 0 54065 PATRICIA GOLDSMITH 40.00 X 339003 0 34944 LISA KIMBRO 40.00 X 237651 0 50671 JOAN MCCLURE 40.00 X 254945 0 34716 KRISTINA M GREGORY 40.00 X 178431 0 27779 EVA M LEPISTO 40.00 X 171335 0 19984 C LYN FITZGERALD 40.00 X 165154 0 49216 DIANE E PAUL 40.00 X 164922 0 37477 LAUREN GALLAGHER 40.00 X 161384 0 42849 2328301 0 351701 9 0 1 0 THE WESTIN DIPLOMAT RESORT 3555 S OCEAN DRIVE HOLLYWOOD FL 33019 CONFERENCE PRODUCTION 1684134 BECKMAN RESEARCH INSTITUTE OF THE CITY O 1500 EAST DUARTE ROAD DUARTE CA 91010 DATA COLLECTION 1260922 MEDSCAPE LLC 12186 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 VIDEO PRODUCTION 981810 DANA-FARBER CANCER INSTITUTE 44 BINNEY STREET BOSTON MA 02115 DATA COLLECTION 812093 PHOENIX LITHOGRAPHING 11631 CAROLINE ROAD PHILADELPHIA PA 19154 PRINTING 753229 32 1915000 86500 20252988 22254488 LICENSE FEES 900099 910000 910000 SUBSCRIPTIONS 900099 856660 856660 REGISTRATION FEES 900099 473213 473213 TUITION 900099 322503 322503 TRENDS SURVEY FEES 900099 140000 140000 59000 59000 2761376 151856 151856 ADVERTISING 541800 236299 236299 236299 25404019 2761376 236299 151856 2026838 2026838 1487075 1064863 273093 149119 5862718 4945414 421477 495827 461931 377273 44515 40143 1032663 843409 99513 89741 448180 366043 43189 38948 355755 197770 157985 38500 38500 750204 750204 1102296 758777 338533 4986 3494904 3494904 122626 122626 91529 48 91481 OUTCOMES DATABASE 4363847 4363847 OTHER EXPENSES 1218645 1006257 207776 4612 ENDURING MATERIALS 1044531 1044531 PRINTING AND PUBLICATIO 995204 1011732 -16528 HONORARIA 510500 510500 970220 757332 211763 1125 26378166 22769538 2784127 824501 200 200 16699051 21484240 8923830 5893633 952040 1860780 200000 519754 369960 3591672 849416 2413357 2742256 29508232 32551069 2938481 2595261 2186399 6454464 5124880 9049725 X 9777161 11345724 14606191 12155620 24383352 23501344 29508232 32551069 X -974147 92139 X X 0 1 1 X 0 X 20358772 25410188 26204857 17970391 22254488 112198696 20358772 25410188 26204857 17970391 22254488 112198696 52361990 59836706 452388 744048 514993 181254 151856 2044539 25601 82175 258498 230364 236299 832937 2622079 3193433 2772976 7129446 2761376 18479310 133555482 564199 0.44800 0.44730 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: PART II SECTION B LINE 10 OTHER INCOME CONSISTS OF THE FOLLOWING ITEMS: TUITION FEES FOR NCCN ACADEMY OF $322,503 LICENSE FEES OF $910,000 FOR LICENSING OF NCCN'S PRODUCTS SUBSCRIPTION REVENUE OF $856,660 FOR THE DRUG & BIOLOGICS COMPENDIUM AND CHEMOTHERAPY ORDER TEMPLATES REGISTRATION FEES OF $473,213 FOR NCCN EDUCATIONAL PROGRAMS TRENDS SURVEY FEES OF $140,000 FOR NCCN TRENDS REPORTS BUSINESS INSIGHTS FEE OF $59,000 FOR NCCN BUSINESS INSIGHTS REPORT RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1000000 1000000 2000000 3000000 107569 13965 121534 250000 250000 500000 750000 203735 12361 191374 3387937 837055 2550882 2742256 25404019 26378166 -974147 92139 92139 -882008 25496158 92139 92139 25404019 0 25404019 26378166 0 26378166 0 26378166 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: NCCN FOLLOWS FASB ISSUED ACCOUNTING STANDARDS UPDATE NO. 2009-06, INCOME TAXES (TOPIC 740): IMPLEMENTATION GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND DISCLOSURE AMENDMENTS FOR NONPUBLIC ENTITIES TAXES. FASB ASC 740 PRESCRIBES GUIDANCE FOR THE FINANCIAL STATEMENT RECOGNITION, MEASUREMENT AND DISCLOSURE OF UNCERTAIN TAX POSITIONS. TAX POSITIONS MUST MEET A MORE-LIKELY-THAN-NOT RECOGNITION THRESHOLD AT THE EFFECTIVE DATE TO BE RECOGNIZED UPON ADOPTION OF THIS STANDARD, WHICH WAS ADOPTED BY NCCN AS OF JANUARY 1, 2009, AS REQUIRED. THE ADOPTION OF THIS STANDARD DID NOT REQUIRE ANY ADJUSTMENTS TO NCCN'S FINANCIAL STATEMENTS. THERE WERE NO TAX POSITIONS FOR WHICH IT IS REASONABLY POSSIBLE THAT THE TOTAL AMOUNTS OF UNRECOGNIZED TAX BENEFITS WILL SIGNIFICANTLY INCREASE OR DECREASE WITHIN THE NEXT YEAR. TAX YEARS FROM 2007 THROUGH 2010 REMAIN SUBJECT TO EXAMINATION BY MAJOR TAX JURISDICTIONS. EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM. 2281 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES JNCCN 35450 SOUTH AMERICA 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM. 8614 0 0 0 46345 0 46345 0 0 0 0 0 0 OTHER INFORMATION SCHEDULE F, PART V PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 BARBARA ANN KARMANOS CANCER CENTER 4100 JOHN ROAD DETROIT MI 48201 201649466 501(C)(3) 17500 RESEARCH CITY OF HOPE COMPREHENSIVE CANCER CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 501(C)(3) 89108 RESEARCH DANA FARBER CANCER CENTER 44 BINNEY STREET BP 317 BOSTON MA 02115 043320640 501(C)(3) 144232 RESEARCH DUKE CANCER INSTITUTE 2200 W MAIN ST STE 810 DURHAM NC 27705 560532129 501(C)(3) 45600 RESEARCH FOX CHASE CANCER CENTER 640 COTTMAN AVENUE CHELTENHAM PA 19012 232003072 501(C)(3) 63749 RESEARCH GEORGIA CANCER SPECIALISTS 1835 SAVOY DRIVE SUITE 300 ATLANTA GA 30341 582181189 N/A 18212 RESEARCH HEALTH RESEARCH ASSOCIATION 1640 MARENGO STREET 7TH FLOOR LOS ANGELES CA 90033 951683862 501(C)(3) 28841 RESEARCH HEALTH RESEARCH INC ROSWELL PARK CANCER CTR ELM AND CARLTON STREET BUFFALO NY 14263 141402155 501(C)(3) 207353 RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 348159 RESEARCH NORTHWESTERN UNIVERSITY 750 N LAKE SHORE DR CHICAGO IL 60611 362167817 501(C)(3) 48762 RESEARCH OHIO STATE UNIVERSITY RESEARCH FOUNDATION 1960 KENNY ROAD COLUMBUS OH 43210 316401599 501(C)(3) 295894 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 89167 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 185 BERRY STREET SUITE 4603 SAN FRANCISCO CA 941431016 946036493 501(C)(3) 26262 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM COMPREHENSIVE CANCER CENTER 1824 6TH AVENUE SOUTH BIRMINGHAM AL 352943300 636005396 501(C)(3) 20589 RESEARCH UNIVERSITY OF NEBRASKA MEDICAL CENTER 985100 NEBRASKA MEDICAL CENTER OMAHA NE 681985100 470049123 501(C)(3) 74942 RESEARCH UNIVERSITY OF TENNESSEE CANCER INSTITUTE 1331 UNION AVENUE SUITE 800 MEMPHIS TN 38104 621715646 N/A 75000 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ROOM 2044 ANN ARBOR MI 48104 386006309 501(C)(3) 144579 RESEARCH UNIVERSITY OF UTAH - HUNTSMAN CANCER INSTITUTE 2000 CIRCLE OF HOPE ROOM 2160 SALT LAKE CITY UT 84112 876000525 501(C)(3) 68050 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE E G2-200 SEATTLE WA 98109 916001537 501(C)(3) 87224 RESEARCH THE UNIVERSITY OF TEXAS - MD ANDERSON CANCER CENTER 1515 HOLCOMBE AVENUE HOUSTON TX 772104390 746001118 501(C)(3) 91944 RESEARCH VANDERBILT UNIV MEDICAL CTR DEPT OF FINANCE AT 40303 ATLANTA GA 311920303 620476822 501(C)(3) 39849 RESEARCH 19 2 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS MUST SIGN A CERTIFICATION FORM WITH AN ATTESTATION THAT THEY WILL ABIDE BY THE TERMS OF THE NCCN RESEARCH AGREEMENT AT ISSUE AND THAT THEY HAVE NOT BEEN DISBARRED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN NINE MONTHS OF APPROVAL, NCCN TERMINATES THE STUDY AND THE STUDY MUST THEN BE RESUBMITTED TO NCCN FOR A NEW REVIEW AND APPROVAL. FUNDING THAT HAD BEEN SUPPLIED BY NCCN TO AN INSTITUTION FOR A STUDY THAT DOES NOT COMMENCE WITHIN THE APPLICABLE SPECIFIED TIME PERIOD MUST BE RETURNED IMMEDIATELY TO NCCN BY THE INSTITUTION. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A QUARTERLY BASIS THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF TOTAL ENROLLMENT, ELIGIBILITY, AND ACCRUAL OF PATIENTS. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARKS FOR PATIENT ACCRUAL ARE MET AND THE FINAL PAYMENT IS DISBURSED UPON RECEIPT OF FINAL REPORTS AND / OR MANUSCRIPTS. X X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM MCGIVNEY PHD 493251 0 162225 0 0 0 24500 0 29565 0 709541 0 0 0 PATRICIA GOLDSMITH 339003 0 0 0 0 0 24500 0 10444 0 373947 0 0 0 LISA KIMBRO 237651 0 0 0 0 0 24211 0 26460 0 288322 0 0 0 JOAN MCCLURE 254945 0 0 0 0 0 24500 0 10216 0 289661 0 0 0 KRISTINA M GREGORY 178431 0 0 0 0 0 18008 0 9771 0 206210 0 0 0 EVA M LEPISTO 171335 0 0 0 0 0 17124 0 2860 0 191319 0 0 0 C LYN FITZGERALD 165154 0 0 0 0 0 17140 0 32076 0 214370 0 0 0 DIANE E PAUL 164922 0 0 0 0 0 16909 0 20568 0 202399 0 0 0 LAUREN GALLAGHER 161384 0 0 0 0 0 10822 0 32027 0 204233 0 0 0 FORM 990, PART VI, SECTION B, LINE 11 NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED EVERY TWO YEARS BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS REQUESTS INFORMATION FROM THE CHIEF OPERATING OFFICER (COO) REGARDING THE CEO'S PAST FIVE YEARS' SALARY HISTORY AS WELL AS THE CEO'S GOALS AND OBJECTIVES. THE EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL WITH THE COO TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. NCCN'S EXECUTIVE COMMITTEE DETERMINES THE CEO'S COMPENSATION IN THE INTERIM YEARS WHEN THE INDEPENDENT ORGANIZATION IS NOT ENGAGED FOR THE SALARY COMPARABILITY STUDY AND SURVEY. PART VI SECTION B. LINE 15B: THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF FINANCIAL OFFICER (CFO), AND SENIOR VICE PRESIDENT OF CLINICAL INFORMATION AND PUBLICATIONS IS REVIEWED EVERY TWO YEARS BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. THE CEO REVIEWS THE SALARY STUDY AND SURVEY AND DISCUSSES THIS INFORMATION WITH NCCN'S EECUTIVE COMMITTEE TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. NCCN'S EXECUTIVE COMMITTEE DETERMINES THE COMPENSATION OF KEY EMPLOYEES IN THE INTERIM YEARS WHEN THE INDEPENDENT ORGANIZATION IS NOT ENGAGED FOR THE SALARY COMPARABILITY STUDY AND SURVEY. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 92,139. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 275 COMMERCE DRIVE STE 300 FORT WASHINGTON PA 19034 271536314 FOUNDATION DE 501(C)(3) LINE 7 N/A 0 0 1 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 NCCN FOUNDATION B 50000 FMV NCCN FOUNDATION D 200000 FMV NCCN FOUNDATION K 86500 FMV NCCN FOUNDATION N 289300 FMV INCLUDED IN SHARING OF PAID EMPLOYEES ARE OTHER EXPENSES AS DETAILED BELOW: PART V LINE 2 (4) SALARIES AND BENEFITS $206,370 PROFESSIONAL FEES 22,122 TRAVEL AND MEETINGS 34,550 OFFICE EXPENSE 5,251 SUPPLIES 7,587 OTHER EXPENSES 12,458 TELEPHONE 962 TOTAL $289,300